This funding opportunity supports research proposals focused on real world evidence regarding the early and appropriate use of Aztreonam-Avibactam (ATM-AVI). Research activities should cover diverse geographic locations including Brazil, Chile, India, Italy, South Africa, Spain, and the United Kingdom. The grant aims to advance understanding of ATM-AVI's impact in clinical settings.
Eligibility criteria are not specified for this funding opportunity.
